Grifols is a global healthcare company that since 1909 has enhanced the health and well-being of people around the world.

We are an industry leader in producing plasma-derived medicines and transfusion medicine.

Our business is organized into four divisions: Bioscience, Diagnostic, Hospital and Bio Supplies.

We sell our products and services in more than 100 countries and regions and have subsidiaries in 30 of them.

We aim to be a global leader in our markets and an industry reference for quality, safety and innovation.

Services:

Creating a positive impact

We are committed to sustainable growth that makes a positive impact on the local areas in which we operate, the scientific community, the environment and society as a whole.

Grifols' corporate responsibility policy is grounded on the core values instilled by our founders. A deep sense of responsibility and a commitment to ethical behavior run throughout our business.

We are proud to have donated �39 million during 2019 to social initiatives around the world.